X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (62) 62
gadolinium (50) 50
radiology, nuclear medicine & medical imaging (44) 44
humans (42) 42
gbca (39) 39
nephrogenic systemic fibrosis (34) 34
magnetic resonance imaging (31) 31
male (23) 23
contrast agents (21) 21
contrast media (21) 21
female (19) 19
dentate nucleus (18) 18
gadolinium-based contrast agents (18) 18
mri (18) 18
contrast media - adverse effects (17) 17
middle aged (17) 17
globus-pallidus (15) 15
gadolinium - adverse effects (13) 13
gadolinium-based contrast agent (13) 13
adult (12) 12
contrast media - pharmacokinetics (11) 11
pharmacokinetics (11) 11
aged (10) 10
article (10) 10
brain (10) 10
contrast media - administration & dosage (10) 10
gadodiamide (10) 10
image enhancement - methods (10) 10
radiology (10) 10
safety (10) 10
t1-weighted mr-images (10) 10
animals (9) 9
gadolinium - pharmacokinetics (9) 9
gbcas (9) 9
magnetic resonance imaging - methods (9) 9
contrast media - metabolism (8) 8
deposition (8) 8
gadobenate dimeglumine (8) 8
high-signal intensity (8) 8
plasma-mass spectroscopy (8) 8
stability (8) 8
blood (7) 7
high signal intensity (7) 7
human bone tissue (7) 7
normal renal-function (7) 7
rats (7) 7
retention (7) 7
adolescent (6) 6
aged, 80 and over (6) 6
contrast agent (6) 6
fibrosis (6) 6
gadobutrol (6) 6
gadopentetate dimeglumine (6) 6
health aspects (6) 6
mass spectrometry (6) 6
medicine & public health (6) 6
toxicity (6) 6
analysis (5) 5
brain - metabolism (5) 5
gadolinium - administration & dosage (5) 5
gadolinium deposition (5) 5
gadoterate meglumine (5) 5
imaging / radiology (5) 5
kontrastmittel (5) 5
liver (5) 5
magnetic resonance (5) 5
mri contrast agents (5) 5
nephrogenic fibrosing dermopathy - chemically induced (5) 5
organometallic compounds - pharmacokinetics (5) 5
original (5) 5
rats, wistar (5) 5
relaxivity (5) 5
reproducibility of results (5) 5
brain - drug effects (4) 4
dermopathy (4) 4
dimeglumine (4) 4
gadolinium - metabolism (4) 4
gadolinium based contrast agents (4) 4
gd-eob-dtpa (4) 4
hyperintense dentate nucleus (4) 4
image enhancement (4) 4
in-vivo (4) 4
kidneys (4) 4
magnetic resonance imaging - adverse effects (4) 4
media (4) 4
nephrogenic fibrosing dermopathy - pathology (4) 4
neuroradiology (4) 4
nsf (4) 4
nuclear magnetic resonance--nmr (4) 4
organometallic compounds - adverse effects (4) 4
prospective studies (4) 4
quantification (4) 4
research (4) 4
retrospective studies (4) 4
risk factors (4) 4
sensitivity and specificity (4) 4
treatment outcome (4) 4
usage (4) 4
abridged index medicus (3) 3
biodistribution (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


04/2016, ISBN 9780128009451
The goal of this chapter is to focus on the current status of the magnetic resonance imaging (MRI) contrast agents in clinical use in neuro-oncology. These are... 
Dynamic contrast-enhanced imaging (DCE-MRI) | Pseudo-response | Gadolinium-based contrast agents (GBCAs) | Nephrogenic systemic fibrosis | Pseudo-progression | Delayed radiation necrosis | Dynamic susceptibility-weighted contrast imaging (DSC-MRI)
Book Chapter
Disegnare con, 06/2016, Volume 9, Issue 16, pp. 1 - 6
Lo sviluppo della progettazione all’interno di software BIM rappresenta idee e forme che derivano da integrazioni interdisciplinari. L’unione fra diverse... 
BIM, GBC Historic BUILDING®, Modeling, Preservation parole chiave: BIM, GBC
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.